Finanzwire Finanzwire
Basculer en Français
9472 Companies
185369 Keywords
117719 Articles
99261 Press releases
Headlines Articles Press releases Pima Heart & Vascular Remove
  1. Home
  2. Companies
  3. Pima Heart & Vascular
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/24/2024 at 14:00, 1 year 10 months ago

    Pima Heart & Vascular Hosts Leading Cardiology Conference in Tucson This February

    Pima Heart & Vascular proudly announces its leadership role in hosting the CardioVascular Interventions Summit (CVIS) 2024. The summit, set for February 16-17 at the El Conquistador Tucson, Arizona, is a pinnacle of collaborative and innovative cardiovascular medicine, featuring a world-class faculty and live case sessions from major medical centers across the country. CVIS 2024 is designed to meet the educational needs of a diverse range of cardiovascular professionals, offering a hybrid conference model for both in-person and virtual attendees. Industry partners have unique opportunities to engage directly with thought leaders, practitioners, and decision-makers in cardiovascular medicine. For more information and to register, please visit CVISummit.com.
    CardioVascular Interventions Summit 2024 Pima Heart & Vascular Cardiovascular Medicine CVIS 2024 Cardiac Care
    Logo of Pima Heart & Vascular
Accesswire
  • Published on 12/05/2025 at 02:35, 3 hours 25 minutes ago

    Future Fuels Initates Drill Permitting at Hornby; Marketing Update

  • Published on 12/05/2025 at 02:30, 3 hours 30 minutes ago

    Klondike Gold Announces AGM Results

  • Published on 12/05/2025 at 01:00, 5 hours ago

    BEACN Closes First Tranche of Non-Brokered Private Placement

  • Published on 12/04/2025 at 23:05, 6 hours 55 minutes ago

    BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025

  • Published on 12/04/2025 at 23:00, 7 hours ago

    NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE
EQS Group
  • Published on 12/05/2025 at 03:30, 2 hours 30 minutes ago

    CGTN: What makes cooperation between China and France a two-way success

  • Published on 12/04/2025 at 23:50, 6 hours 9 minutes ago

    EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes

  • Published on 12/04/2025 at 20:25, 9 hours 35 minutes ago

    Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions

  • Published on 12/04/2025 at 20:15, 9 hours 45 minutes ago

    Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

  • Published on 12/04/2025 at 19:10, 10 hours 50 minutes ago

    SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

View all EQS
Les Echos
  • Published on 12/04/2025 at 18:00, 12 hours ago

    Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025

  • Published on 12/04/2025 at 17:45, 12 hours 15 minutes ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

  • Published on 12/04/2025 at 17:44, 12 hours 16 minutes ago

    Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution

  • Published on 12/04/2025 at 07:01, 22 hours 59 minutes ago

    bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

  • Published on 12/03/2025 at 18:00, 1 day 12 hours ago

    Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2025 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy